Ronner, E <br/><br/>
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study.  [electronic resource] 

 -  European heart journal  Sep 2000 
 - 1530-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0195-668X 
<br/><br/><label>Standard No.: </label>10.1053/euhj.1999.2035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aspirin--therapeutic use<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Eptifibatide<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Peptides--administration & dosage<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Streptokinase--therapeutic use<br/>Thrombolytic Therapy<br/>Treatment Outcome